Chemoinformaics analysis of 2-BENZYL-4-METHOXYQUINAZOLINE
Molecular Weight | 250.301 | nRot | 3 |
Heavy Atom Molecular Weight | 236.189 | nRig | 17 |
Exact Molecular Weight | 250.111 | nRing | 3 |
Solubility: LogS | -4.136 | nHRing | 1 |
Solubility: LogP | 3.865 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
No. of Oxygen atom | 1 | No. of Arom Bond | 17 |
nHA | 3 | APOL | 39.0571 |
nHD | 0 | BPOL | 18.0609 |
QED | 0.715 |
Synth | 1.82 |
Natural Product Likeliness | -0.985 |
NR-PPAR-gamma | 0.085 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.013 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.678 |
MDCK | 0.000035 |
BBB | 0.413 |
PPB | 0.970852 |
VDSS | 0.801 |
FU | 0.0170908 |
CYP1A2-inh | 0.964 |
CYP1A2-sub | 0.784 |
CYP2c19-inh | 0.95 |
CYP2c19-sub | 0.097 |
CYP2c9-inh | 0.885 |
CYP2c9-sub | 0.22 |
CYP2d6-inh | 0.094 |
CYP2d6-sub | 0.332 |
CYP3a4-inh | 0.779 |
CYP3a4-sub | 0.868 |
CL | 6.822 |
T12 | 0.585 |
hERG | 0.061 |
Ames | 0.333 |
ROA | 0.126 |
SkinSen | 0.243 |
Carcinogencity | 0.245 |
EI | 0.155 |
Respiratory | 0.93 |
NR-Aromatase | 0.021 |
Antiviral | Yes |
Prediction | 0.69032 |